Strategic partnerships Strong relationships with global pharma leaders (Pfizer, AbbVie, Gilead, Eli Lilly, Novavax, Sanofi) indicate opportunities to cross-sell by offering sponsor-friendly site management, fast-start trial setup, and high-quality data services to other sponsors seeking provider-based execution.

Sponsor bridge Position as the bridge between sponsors and providers to accelerate patient access to breakthrough therapies, suggesting sales plays around streamlined enrollment, rapid start-up, and enhanced patient-centered trial experiences.

Site network leverage Two high-performing research sites and relations with 200+ hospitals/provider groups present a scalable footprint for expanding trials in new geographies or therapeutic areas, with a need for additional site activation and management services.

Financial health Revenue in the mid single to low double digits (1M-10M) indicates an opportunity to upsell premium trial management solutions, cloud-based data integrity tools, and advanced analytics to improve efficiency and scale margins.

Tech modernization Existing tech stack shows familiarity with cloud, CMS, e-commerce, and security frameworks; sales can emphasize compliant data platforms, secure communications, and integration-ready solutions to modernize trial operations for sponsors seeking robust tech readiness.